Results 1 to 10 of about 75,705 (253)
Drug Design, Development and Therapy, 2015 Ling Hou,1,* Zhi-hang Chen,2,* Dong Liu,3 Yuan-guo Cheng,2 Xiao-ping Luo1 1Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 2Department of Pharmacy, Beijing Institute of ...
Hou L, Chen ZH, Liu D, Cheng YG, Luo XP
doaj +5 more sources
Growth Hormone Antibodies Formation in Patients Treated with Recombinant Human Growth Hormone [PDF]
International Journal of Immunopathology and Pharmacology, 2004 Human growth hormone (hGH) is normally produced by acidophilic cells of the anterior lobe of the pituitary gland. Recombinant DNA technology has made it possible to produce rhGH. There have been reports of immunological reactions in patients treated with rhGH.
Mohammad Hossein Sanati
exaly +3 more sources
Recombinant human growth hormone in the treatment of Turner syndrome
Therapeutics and Clinical Risk Management, 2008 Bessie E SpiliotisDivision of Pediatric Endocrinology and Diabetes, Department of Pediatrics, University of Patras, School of Medicine, Patras, GreeceAbstract: Turner syndrome (TS) is a common chromosomal disorder in women that is associated with the ...
Bessie E Spiliotis
doaj +4 more sources
Italian Journal of Pediatrics, 2019 Background The treatment with recombinant human growth hormone in patients affected by Mucopolysaccharidoses (MPS) is considered whenever a concurrent diagnosis of growth hormone deficiency is demonstrated. The short- and long-term effects of recombinant
A. Cattoni +5 more
doaj +3 more sources
European Journal of Inflammation, 2019 This study aims to investigate the effects of recombinant human growth hormone (rhGH) on serum nesfatin-1 and ghrelin in children with growth hormone deficiency (GHD), in order to provide a reliable basis for the effectiveness and safety of applying rhGH
Yu Wang +3 more
doaj +2 more sources
Effectiveness of Recombinant Human Growth Hormone for Pharyngocutaneous Fistula Closure [PDF]
Clinical and Experimental Otorhinolaryngology, 2015 ObjectivesIn laryngeal cancer, which comprises 25% of head and neck cancer, chemotherapy has come into prominence with the increase in organ-protective treatments.
Nurten Kucuk +5 more
doaj +1 more source
Laron syndrome: An experience of treatment of two cases
Journal of Clinical and Translational Endocrinology Case Reports, 2021 Laron syndrome or growth hormone insensitivity is a rare disease presenting with severe postnatal growth failure. Clinically, in most circumstances, it is indistinguishable from growth hormone deficiency.
Hiya Boro +4 more
doaj +1 more source
Adverse events of replacement therapy in children with growth hormone deficiency
Zdorovʹe Rebenka, 2023 Background. The purpose was to analyze and summarize the accumulated short-term and long-term safety data in children with growth hormone deficiency (GHD) treated using recombіnant human growth hormone (rhGH) based on the results of a physical ...
M. Aryayev, L. Senkivska
doaj +1 more source
Vitamin D and Parathyroid Hormone during Growth Hormone Treatment
Children, 2022 Background. There is some controversy concerning a potential interaction between vitamin D and PTH and the GH/IGF-1 axis. The goal of this study is to assess vitamin D and PTH status in children with GH deficiency at diagnostic and during treatment with ...
Teodoro Durá-Travé +1 more
doaj +1 more source
Response to three years of growth hormone therapy in girls with Turner syndrome [PDF]
Annals of Pediatric Endocrinology & Metabolism, 2013 PurposeShort stature is the most common finding in patients with Turner syndrome. Improving the final adult height in these patients is a challenge both for the patients and physicians.
Hong Kyu Park +4 more
doaj +1 more source